First Eagle Investment Management, LLC Assertio Holdings, Inc. Transaction History

First Eagle Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$5.0 - $7.66 $888,250 - $1.36 Million	177,650 Added 20.66%	1,037,604 $5.62 Million
Q1 2023 May 11, 2023	BUY	$3.54 - $6.66 $608,451 - $1.14 Million	171,879 Added 24.98%	859,954 $5.48 Million
Q4 2022 Feb 09, 2023	BUY	$2.11 - $4.3 $396,840 - $808,726	188,076 Added 37.62%	688,075 $2.96 Million
Q3 2022 Nov 10, 2022	BUY	$2.13 - $4.0 $532,384 - $999,784	249,946 Added 99.96%	499,999 $1.14 Million
Q2 2022 Aug 10, 2022	BUY	$1.88 - $3.42 $470,099 - $855,181	250,053 New	250,053 $738,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $40.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.